Middle EAST Differentiated Thyroid Cancer Therapeutics Market Analysis Report: Growth Factors, Challenges, and Opportunities
The Middle EAST Differentiated Thyroid Cancer Therapeutics Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by several factors, including the rising incidence of differentiated thyroid cancer (DTC), advancements in therapeutic options, and increasing awareness regarding early...
0 Yorumlar 0 hisse senetleri 47 Views